Cullinan Associates’s Accenture ACN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $497K | Sell |
2,505
-2,934
| -54% | -$684K | 0.04% | 157 |
|
|
2025
Q4 | $1.46M | Sell |
5,439
-1,401
| -20% | -$356K | 0.1% | 113 |
|
|
2025
Q3 | $1.69M | Sell |
6,840
-1,539
| -18% | -$401K | 0.11% | 113 |
|
|
2025
Q2 | $2.5M | Buy |
8,379
+145
| +2% | +$44.2K | 0.17% | 101 |
|
|
2025
Q1 | $2.57M | Sell |
8,234
-90
| -1% | -$31.8K | 0.18% | 97 |
|
|
2024
Q4 | $2.93M | Sell |
8,324
-963
| -10% | -$347K | 0.19% | 88 |
|
|
2024
Q3 | $3.49M | Sell |
9,287
-668
| -7% | -$220K | 0.2% | 88 |
|
|
2024
Q2 | $3.02M | Sell |
9,955
-5,127
| -34% | -$1.57M | 0.17% | 93 |
|
|
2024
Q1 | $5.23M | Sell |
15,082
-13,207
| -47% | -$4.81M | 0.29% | 72 |
|
|
2023
Q4 | $9.93M | Sell |
28,289
-7,889
| -22% | -$2.54M | 0.55% | 39 |
|
|
2023
Q3 | $11.1M | Sell |
36,178
-7,886
| -18% | -$2.48M | 0.65% | 39 |
|
|
2023
Q2 | $13.6M | Sell |
44,064
-8,698
| -16% | -$2.53M | 0.75% | 31 |
|
|
2023
Q1 | $15.1M | Buy |
52,762
+12,454
| +31% | +$3.4M | 0.88% | 28 |
|
|
2022
Q4 | $10.8M | Buy |
40,308
+10,212
| +34% | +$2.82M | 0.6% | 38 |
|
|
2022
Q3 | $7.74M | Buy |
30,096
+1,322
| +5% | +$382K | 0.49% | 55 |
|
|
2022
Q2 | $7.99M | Buy |
28,774
+3,674
| +15% | +$1.1M | 0.49% | 53 |
|
|
2022
Q1 | $8.46M | Buy |
25,100
+5,461
| +28% | +$1.84M | 0.44% | 62 |
|
|
2021
Q4 | $8.14M | Sell |
19,639
-42,336
| -68% | -$15.4M | 0.41% | 68 |
|
|
2021
Q3 | $19.8M | Buy |
61,975
+3,228
| +5% | +$1.05M | 1.1% | 18 |
|
|
2021
Q2 | $17.3M | Buy |
58,747
+14,538
| +33% | +$4.16M | 0.97% | 22 |
|
|
2021
Q1 | $12.2M | Sell |
44,209
-195
| -0.4% | -$50.4K | 0.7% | 34 |
|
|
2020
Q4 | $11.6M | Sell |
44,404
-472
| -1% | -$113K | 0.7% | 34 |
|
|
2020
Q3 | $10.1M | Buy |
44,876
+13,431
| +43% | +$3.08M | 0.65% | 34 |
|
|
2020
Q2 | $6.75M | Buy |
31,445
+293
| +0.9% | +$55.4K | 0.47% | 55 |
|
|
2020
Q1 | $5.09M | Sell |
31,152
-35
| -0.1% | -$6.74K | 0.42% | 65 |
|
|
2019
Q4 | $6.57M | Buy |
31,187
+1,270
| +4% | +$248K | 0.44% | 66 |
|
|
2019
Q3 | $5.75M | Buy |
29,917
+775
| +3% | +$150K | 0.41% | 69 |
|
|
2019
Q2 | $5.38M | Buy |
29,142
+2,757
| +10% | +$495K | 0.39% | 75 |
|
|
2019
Q1 | $4.64M | Buy |
26,385
+185
| +0.7% | +$29.1K | 0.35% | 83 |
|
|
2018
Q4 | $3.69M | Buy |
26,200
+2,025
| +8% | +$320K | 0.31% | 83 |
|
|
2018
Q3 | $4.12M | Sell |
24,175
-125
| -0.5% | -$20.8K | 0.3% | 91 |
|
|
2018
Q2 | $3.98M | Sell |
24,300
-775
| -3% | -$121K | 0.3% | 89 |
|
|
2018
Q1 | $3.85M | Sell |
25,075
-1,175
| -4% | -$186K | 0.29% | 90 |
|
|
2017
Q4 | $4.02M | Buy |
26,250
+3,900
| +17% | +$565K | 0.3% | 90 |
|
|
2017
Q3 | $3.02M | Buy |
22,350
+5,575
| +33% | +$726K | 0.23% | 103 |
|
|
2017
Q2 | $2.08M | Buy |
+16,775
| New | +$2.04M | 0.16% | 112 |
|
Other funds holding ACN
VCM
VPM
Cullinan Associates's ACN Position: Q1 2026 in Review
Cullinan Associates reduced its Accenture (ACN) stake by 54% in Q1 2026, selling an estimated $684K and leaving 2,505 shares worth $497K. The position accounts for 0.04% of the portfolio, ranked #157.
Cullinan Associates first reported a position in ACN in Q2 2017 and has held it in 36 quarters since. The position peaked at $19.8M in Q3 2021. 2,149 funds tracked by Wall St. Rank hold ACN as of Q1 2026.
- Cullinan Associates held 2,505 shares of Accenture worth $497K as of Q1 2026.
- Cullinan Associates sold 2,934 Accenture shares in Q1 2026, an estimated $684K.
- Accenture made up 0.04% of Cullinan Associates's portfolio in Q1 2026, its #157 holding.
- Cullinan Associates first reported a position in Accenture in Q2 2017 and has held it in 36 quarters since.
- Cullinan Associates's Accenture position peaked at $19.8M in Q3 2021.
- 2,149 funds tracked by Wall St. Rank held Accenture as of Q1 2026.
Based on Cullinan Associates's 13F filing for Q1 2026, filed 1 May 2026.